JAZZ — Jazz Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapSuper Stock

Annual balance sheet for Jazz Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,133	591	881	1,626	2,993
Net Total Accounts Receivable
Net Total Receivables	396	563	743	855	717
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,840	2,611	2,606	3,435	4,629
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	257	343	301	235	227
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	6,536	12,299	10,835	11,393	12,012
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	654	809	933	1,537	1,039
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	2,876	8,333	7,750	7,656	7,919
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	3,660	3,965	3,086	3,737	4,094
Total Liabilities & Shareholders' Equity	6,536	12,299	10,835	11,393	12,012
Total Common Shares Outstanding